(Q39664079)

13 September 2017

Rauwolfia serpentina (serpasil) in psychiatry (English)

1 reference

13 September 2017

GLYNN JD

1

1 reference

PMC publication ID

503243

13 September 2017

language of work or name

English

0 references

publication date

1 August 1955

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

13 September 2017

1 reference

13 September 2017

18

1 reference

13 September 2017

3

1 reference

13 September 2017

225-227

1 reference

Characterization of central effects of serpasil (reserpin, a new alkaloid of Rauwolfia serpentina B.) and of their antagonistic reactions.

13 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=503243

[Reserpin, the sedative principle from Rauwolfia serpentina B]

21 August 2018

1 reference

12 December 2020

New drug therapies in arterial hypertension

1 reference

12 December 2020

Cardiovascular and respiratory effects of serpasil, a new crystalline alkaloid from Rauwolfia serpentina Benth, in the dog

1 reference

12 December 2020

Reserpine in the treatment of hypertension; a note on the relative dosage and effects

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.18.3.225

1 reference

13 September 2017

1 reference

PMC publication ID

503243

13 September 2017

PubMed publication ID

13252432

1 reference

PMC publication ID

503243